Glenmark introduces 3-in-1 inhaler therapy for COPD promising reductionin risk of severe attacks and improvement in lung function

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of a Single Inhaler Triple Therapy AIRZ-FF – a combination of two bronchodilators, Glycopyrronium & Formoterol and the inhalation corticosteroid Fluticasone […]